Clinical Trial Update: Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on tegaserod for opioid-induced constipation in adults with non-cancer pain; the Phase 2/3 study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Opioid-induced Constipation

Drugs mentioned

• Tegaserod (tegaserod)

Snippet

Sponsor: Novartis | Conditions: Constipation | Phase 2, Phase 3 | Status: TERMINATED